Abstract
EU Member States are obliged to apply the “Do no significant harm” principle in their public procurement procedures when their projects are financed under the EU Recovery and Resilience Facility (RRF). Despite the binding nature of this novel principle, doubts persist around its scope and implications. This contribution aims at tracing the evolution of the “no-harm” rule, which is recognised as a rule of customary international law at the international level while in the EU it was elaborated as a mandatory condition on public procurement contracts falling under the RRF framework.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
